FDA — authorised 5 April 2002
- Application: ANDA075521
- Marketing authorisation holder: RUBICON RESEARCH
- Status: supplemented
FDA authorised Buspirone HCl on 5 April 2002
Yes. FDA authorised it on 5 April 2002.
RUBICON RESEARCH holds the US marketing authorisation.